Agilent Technologies Return on Tangible Equity 2010-2025 | A
Current and historical return on tangible equity values for Agilent Technologies (A) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Agilent Technologies Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-04-30 | $1.17B | $1.17B | 99.85% |
| 2025-01-31 | $1.26B | $1.08B | 94.34% |
| 2024-10-31 | $1.29B | $0.87B | 85.48% |
| 2024-07-31 | $1.41B | $1.55B | 86.05% |
| 2024-04-30 | $1.24B | $1.83B | 81.52% |
| 2024-01-31 | $1.24B | $1.78B | 93.94% |
| 2023-10-31 | $1.24B | $1.41B | 115.32% |
| 2023-07-31 | $1.13B | $1.07B | 132.40% |
| 2023-04-30 | $1.35B | $1.00B | 204.31% |
| 2023-01-31 | $1.32B | $0.82B | 277.07% |
| 2022-10-31 | $1.25B | $0.53B | 370.18% |
| 2022-07-31 | $1.33B | $0.29B | 422.93% |
| 2022-04-30 | $1.26B | $0.27B | 561.33% |
| 2022-01-31 | $1.21B | $0.26B | 1258.49% |
| 2021-10-31 | $1.21B | $0.43B | 928.98% |
| 2021-07-31 | $0.99B | $-0.06B | 750.00% |
| 2021-04-30 | $0.93B | $-0.25B | 339.76% |
| 2021-01-31 | $0.81B | $0.40B | 202.12% |
| 2020-10-31 | $0.72B | $0.44B | 204.84% |
| 2020-07-31 | $0.69B | $0.50B | 273.12% |
| 2020-04-30 | $0.68B | $0.27B | 166.38% |
| 2020-01-31 | $0.76B | $0.20B | 107.15% |
| 2019-10-31 | $1.07B | $0.05B | 107.40% |
| 2019-07-31 | $1.07B | $1.13B | 84.94% |
| 2019-04-30 | $1.12B | $1.48B | 88.67% |
| 2019-01-31 | $1.14B | $1.34B | 86.87% |
| 2018-10-31 | $0.32B | $1.11B | 23.13% |
| 2018-07-31 | $0.30B | $1.12B | 19.15% |
| 2018-04-30 | $0.24B | $1.69B | 14.09% |
| 2018-01-31 | $0.20B | $1.55B | 12.10% |
| 2017-10-31 | $0.68B | $1.87B | 43.77% |
| 2017-07-31 | $0.63B | $1.62B | 44.44% |
| 2017-04-30 | $0.58B | $1.43B | 42.70% |
| 2017-01-31 | $0.51B | $1.33B | 39.63% |
| 2016-10-31 | $0.46B | $1.31B | 37.96% |
| 2016-07-31 | $0.48B | $1.38B | 38.75% |
| 2016-04-30 | $0.46B | $1.12B | 38.66% |
| 2016-01-31 | $0.46B | $1.06B | 36.90% |
| 2015-10-31 | $0.40B | $1.36B | 30.56% |
| 2015-07-31 | $0.28B | $1.26B | 18.35% |
| 2015-04-30 | $0.31B | $1.30B | 18.82% |
| 2015-01-31 | $0.37B | $1.33B | 20.61% |
| 2014-10-31 | $0.50B | $2.15B | 27.14% |
| 2014-07-31 | $0.69B | $1.87B | 42.56% |
| 2014-04-30 | $0.71B | $1.74B | 52.01% |
| 2014-01-31 | $0.74B | $1.57B | 58.57% |
| 2013-10-31 | $0.72B | $1.33B | 61.70% |
| 2013-07-31 | $0.94B | $0.85B | 84.47% |
| 2013-04-30 | $1.01B | $1.31B | 91.47% |
| 2013-01-31 | $1.10B | $1.21B | 75.26% |
| 2012-10-31 | $1.15B | $1.07B | 64.66% |
| 2012-07-31 | $1.02B | $0.84B | 48.55% |
| 2012-04-30 | $1.10B | $2.73B | 45.53% |
| 2012-01-31 | $1.05B | $2.49B | 47.26% |
| 2011-10-31 | $1.01B | $2.32B | 51.80% |
| 2011-07-31 | $1.02B | $2.16B | 59.87% |
| 2011-04-30 | $0.89B | $1.91B | 64.48% |
| 2011-01-31 | $0.80B | $1.42B | 58.35% |
| 2010-10-31 | $0.68B | $1.29B | 46.86% |
| 2010-07-31 | $0.42B | $0.90B | 26.71% |
| 2010-04-30 | $0.19B | $1.86B | 11.00% |
| 2010-01-31 | $-0.02B | $1.79B | -0.95% |
| 2009-10-31 | $-0.03B | $1.69B | -1.87% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $35.696B | $6.510B |
| Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $230.889B | 27.07 |
| Boston Scientific (BSX) | United States | $156.325B | 37.28 |
| Stryker (SYK) | United States | $149.639B | 30.46 |
| EssilorLuxottica (ESLOY) | France | $141.259B | 0.00 |
| Medtronic (MDT) | Ireland | $119.046B | 16.78 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.750B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.937B | 25.13 |
| ResMed (RMD) | United States | $40.192B | 28.75 |
| GE HealthCare Technologies (GEHC) | United States | $33.662B | 15.82 |
| Terumo (TRUMY) | Japan | $26.606B | 31.53 |
| Koninklijke Philips (PHG) | Netherlands | $26.557B | 17.57 |
| Insulet (PODD) | United States | $23.925B | 80.16 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.018B | 13.38 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $16.402B | 0.00 |
| Baxter (BAX) | United States | $12.681B | 9.80 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Demant (WILYY) | Denmark | $8.121B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.061B | 29.61 |
| Lantheus Holdings (LNTH) | United States | $3.733B | 10.09 |
| Envista Holdings (NVST) | United States | $3.520B | 24.63 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.349B | 14.86 |
| Perrigo (PRGO) | Ireland | $3.266B | 8.16 |
| ICU Medical (ICUI) | United States | $3.151B | 21.45 |
| Haemonetics (HAE) | United States | $2.628B | 11.73 |
| Acuren (TIC) | United States | $2.261B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $2.213B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $2.159B | 46.29 |
| QuidelOrtho (QDEL) | United States | $1.948B | 12.26 |
| Green Thumb Industries (GTBIF) | United States | $1.840B | 79.00 |
| AtriCure (ATRC) | United States | $1.838B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.519B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.503B | 17.74 |
| AdaptHealth (AHCO) | United States | $1.284B | 18.25 |
| Neogen (NEOG) | United States | $1.249B | 19.83 |
| BioLife Solutions (BLFS) | United States | $1.200B | 2505.00 |
| InMode (INMD) | Israel | $0.944B | 8.74 |
| Kestra Medical Technologies (KMTS) | United States | $0.829B | 0.00 |
| Valneva SE (VALN) | France | $0.753B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.740B | 0.00 |
| SNDL (SNDL) | Canada | $0.704B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.618B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.615B | 0.00 |
| ZimVie (ZIMV) | United States | $0.532B | 20.52 |
| Evolus (EOLS) | United States | $0.494B | 0.00 |
| Surmodics (SRDX) | United States | $0.487B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.479B | 16.50 |
| CeriBell (CBLL) | United States | $0.434B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.432B | 0.00 |
| Owens & Minor (OMI) | United States | $0.379B | 3.36 |
| Sanuwave Health (SNWV) | United States | $0.357B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.352B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.306B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.300B | 0.00 |
| Brainsway (BWAY) | Israel | $0.294B | 59.85 |
| High Tide (HITI) | Canada | $0.292B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.287B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.286B | 21.68 |
| Omeros (OMER) | United States | $0.283B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.260B | 0.00 |
| Cerus (CERS) | United States | $0.251B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.242B | 0.00 |
| Organigram Global (OGI) | Canada | $0.232B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.219B | 0.00 |
| Exagen (XGN) | United States | $0.217B | 0.00 |
| Quanterix (QTRX) | United States | $0.211B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.199B | 16.63 |
| FitLife Brands (FTLF) | United States | $0.175B | 0.00 |
| Biote (BTMD) | United States | $0.170B | 5.64 |
| Jushi Holdings (JUSHF) | United States | $0.149B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.114B | 0.00 |
| MacroGenics (MGNX) | United States | $0.112B | 0.00 |
| Jin Medical (ZJYL) | China | $0.111B | 0.00 |
| Fonar (FONR) | United States | $0.099B | 12.78 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.090B | 0.00 |
| Apyx Medical (APYX) | United States | $0.075B | 0.00 |
| Agape ATP (ATPC) | $0.066B | 0.00 | |
| Safety Shot (SHOT) | United States | $0.062B | 0.00 |
| MariMed (MRMD) | United States | $0.060B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.059B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.059B | 0.00 |
| ImmuCell (ICCC) | United States | $0.058B | 33.68 |
| Zynex (ZYXI) | United States | $0.050B | 0.00 |
| Veru (VERU) | United States | $0.048B | 0.00 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| Nephros (NEPH) | United States | $0.040B | 31.08 |
| United-Guardian (UG) | United States | $0.039B | 15.02 |
| Senestech (SNES) | United States | $0.024B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.017B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Cellectar Biosciences (CLRB) | United States | $0.016B | 0.00 |
| Sharps Technology (STSS) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |